Osteomyelitis Risk Factors Related to Combat Trauma Open Femur Fractures: A Case-Control Analysis.


Journal

Journal of orthopaedic trauma
ISSN: 1531-2291
Titre abrégé: J Orthop Trauma
Pays: United States
ID NLM: 8807705

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 21 12 2018
medline: 1 7 2020
entrez: 21 12 2018
Statut: ppublish

Résumé

To identify the risk factors for osteomyelitis development in US military personnel with combat-related, open femur fractures? Retrospective observational case-control study. US military regional hospital in Germany and tertiary care hospitals in United States (2003-2009). One hundred three patients with open femur fractures who met diagnostic osteomyelitis criteria (medical record review verification) were classified as cases. Sixty-four patients with open femur fractures who did not meet osteomyelitis diagnostic criteria were included as controls. The main outcome measurements were multivariable odds ratios (ORs) and 95% confidence interval (CI). Among patients with surgical implants, osteomyelitis cases had significantly longer time to definitive orthopaedic surgery compared with controls (median: 21 vs. 13 days). Independent predictors for osteomyelitis risk were Gustilo-Anderson classification (transfemoral amputation OR: 19.3; CI: 3.0-123.0) and Orthopaedic Trauma Association Open Fracture Classification for muscle loss (OR: 5.7; CI: 1.3-25.1) and dead muscle (OR: 32.9; CI: 5.4-199.1). Being injured between 2003 and 2006, antibiotic bead use, and foreign body plus implant(s) at fracture site were also risk factors. Patients with open femur fractures resulting in significant muscle damage have the highest osteomyelitis risk. Foreign body contamination was only significant when an implant was present. Increased risk with antibiotic bead use is likely a surrogate for clinical suspicion of contamination with complex wounds. The timeframe association is likely due to changing trauma system patterns around 2006-2007 (eg, increased negative pressure wound therapy, reduced high-pressure irrigation, decreased crystalloid use, and delayed definitive internal fixations). Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

Identifiants

pubmed: 30570616
doi: 10.1097/BOT.0000000000001397
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e110-e119

Investigateurs

Anuradha Ganesan (A)
Tyler Warkentien (T)
Joseph R Hsu (JR)
Jamie Fraser (J)
Denise Bennett (D)
Adriana McClung (A)
William Bradley (W)
Lauren Greenberg (L)
Jiahong Xu (J)

Auteurs

Louis R Lewandowski (LR)

Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD. Dr. Lewandowski is now with the Department of Orthopaedics, United States Naval Hospital, Okinawa, Japan.

Benjamin K Potter (BK)

Department of Surgery, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD. Dr. Lewandowski is now with the Department of Orthopaedics, United States Naval Hospital, Okinawa, Japan.

Clinton K Murray (CK)

Brooke Army Medical Center, JBSA Fort Sam Houston, San Antonio, TX.

Joseph Petfield (J)

Brooke Army Medical Center, JBSA Fort Sam Houston, San Antonio, TX.

Daniel J Stinner (DJ)

Brooke Army Medical Center, JBSA Fort Sam Houston, San Antonio, TX.

Margot Krauss (M)

Westat, Rockville, MD.

Amy C Weintrob (AC)

Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD.
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, MD.
Infectious Disease, Walter Reed National Military Medical Center, Bethesda, MD.

David R Tribble (DR)

Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH